FR2290220A2 - Nouveau vaccin antirabique - Google Patents

Nouveau vaccin antirabique

Info

Publication number
FR2290220A2
FR2290220A2 FR7436736A FR7436736A FR2290220A2 FR 2290220 A2 FR2290220 A2 FR 2290220A2 FR 7436736 A FR7436736 A FR 7436736A FR 7436736 A FR7436736 A FR 7436736A FR 2290220 A2 FR2290220 A2 FR 2290220A2
Authority
FR
France
Prior art keywords
vaccine
medium
contg
cells
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7436736A
Other languages
English (en)
French (fr)
Other versions
FR2290220B2 (enrdf_load_stackoverflow
Inventor
Pascou Atanasiu
Henri Tsiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR7436736A priority Critical patent/FR2290220A2/fr
Priority to OA55421A priority patent/OA04947A/xx
Publication of FR2290220A2 publication Critical patent/FR2290220A2/fr
Application granted granted Critical
Publication of FR2290220B2 publication Critical patent/FR2290220B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7436736A 1974-02-26 1974-11-05 Nouveau vaccin antirabique Granted FR2290220A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7436736A FR2290220A2 (fr) 1974-11-05 1974-11-05 Nouveau vaccin antirabique
OA55421A OA04947A (fr) 1974-02-26 1975-02-20 Procédé pour l'obtention d'un nouveau vaccin antirabique.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436736A FR2290220A2 (fr) 1974-11-05 1974-11-05 Nouveau vaccin antirabique

Publications (2)

Publication Number Publication Date
FR2290220A2 true FR2290220A2 (fr) 1976-06-04
FR2290220B2 FR2290220B2 (enrdf_load_stackoverflow) 1978-07-21

Family

ID=9144679

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7436736A Granted FR2290220A2 (fr) 1974-02-26 1974-11-05 Nouveau vaccin antirabique

Country Status (1)

Country Link
FR (1) FR2290220A2 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585266A (en) * 1969-02-24 1971-06-15 Dow Chemical Co Live rabies virus vaccine and method for the production thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WORLD HEALTH ORGANIZATION TECHNICAL REPORT SERIES, NO. 523, GENEVE 1973 ) *

Also Published As

Publication number Publication date
FR2290220B2 (enrdf_load_stackoverflow) 1978-07-21

Similar Documents

Publication Publication Date Title
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
GB1292803A (en) Improvements relating to the production of antigens
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
FR2290220A2 (fr) Nouveau vaccin antirabique
ES432385A1 (es) Un metodo de obtener una cepa de virus de la gripe.
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
ES385968A1 (es) Metodo para producir una vacuna de virus de enfermedad de newcastle muy atenuado.
GB1039722A (en) Process for the manufacture of a foot-and-mouth disease vaccine containing a live virus
ES486441A0 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
GB1486557A (en) Process for the preparation of pyrogen-free sub-unit vaccine
GB878704A (en) Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
GB1015262A (en) Virus culture
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
GB953992A (en) Vaccine products and method of preparing same
FR2261779A1 (en) Anti-rabies vaccine - obtd. from rabies virus grown on foetal calf kidney cells in a synthetic serum-free medium
ES347035A1 (es) Procedimiento de preparacion de una vacuna contra la rabia.
GB811411A (en) Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom
GB931137A (en) A method of producing canine distemper vaccine
SU99970A1 (ru) Способ получени столбн чного анатоксина
IE41024B1 (en) Process for obtaining antigens from schistosomes, agent containing these antigens and its use
CH410982A (fr) Procédé de préparation de l'acide N-(2,3-diméthyl-phényl)-anthranilique
CH411923A (fr) Procédé de préparation de l'acide N-(2,3-diméthyl-phényl)-anthranilique
FR2134116A1 (en) Oral influenza vaccine prodn - by culture on chicken kidney tissue
GB1020531A (en) Improvements in plague vaccines
ES224455A1 (es) PROCEDIMIENTO DE PREPARACIoN DE VACUNAS DE TROPISMO TISULAR